HKU Scholars Hub: Browsing DSpace

Browsing by Author Chan, SL

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 25 to 41 of 41 < previous

	Title	Author(s)	Issue Date	Views
	Preclinical evaluation of combined TKI-258 and RAD001 in hepatocellular carcinoma Journal:Cancer Chemotherapy and Pharmacology	Chan, SL Wong, C-H Lau, CPY Zhou, Q Hui, CWC Lui, VWY Ma, BBY Chan, ATC Yeo, W	2013	60
	Prevalence and predictors of default from tuberculosis treatment in Hong Kong	Chan-Yeung, MMW Noertjojo, K Leung, CC Chan, SL Tam, CM	2003	125
	Randomised phase II study of axitinib versus placebo plus best supportive care in second-line treatment of advanced hepatocellular carcinoma Journal:Annals of Oncology	Kang, YK Yau, TCC Park, JW Lim, HY Lee, TY Obi, S Chan, SL Qin, S Kim, RD Casey, M Chen, C Bhattacharyya, H Williams, JA Valota, O Chakrabarti, D Kudo, M	2015
	Randomized, open-label phase 2 study comparing frontline dovitinib versus sorafenib in patients with advanced hepatocellular carcinoma Journal:Hepatology	Cheng, AL Thongprasert, S Lim, HY Sukeepaisarnjaroen, W Yang, TS Wu, CC Chao, Y Chan, SL Kudo, M Ikeda, M Kang, YK Pan, H Numata, K Han, G Balsara, B Zhang, Y Rodriguez, AM Zhang, Y Wang, Y Poon, RTP	2016	93
	Second-line cabozantinib after sorafenib treatment for advanced hepatocellular carcinoma: a subgroup analysis of the phase 3 CELESTIAL trial Journal:ESMO Open	Kelley, RK Ryoo, BY Merle, P Park, JW Bolondi, L Chan, SL Lim, HY Baron, AD Parnis, F Knox, J Cattan, S Yau, T Lougheed, JC Milwee, S El-Khoueiry, AB Cheng, AL Meyer, T Abou-Alfa, GK	2020
	Serum alpha-fetoprotein levels and clinical outcome in the phase 3 CELESTIAL study of cabozantinib versus placebo in patients with advanced hepatocellular carcinoma Journal:Clinical Cancer Research	Kelley, RK Meyer, T Rimassa, L Merle, P Park, JW Yau, T Chan, SL Blanc, JF Tam, VC Tran, A Dadduzio, V Markby, DW Kaldate, R Cheng, AL El-Khoueiry, AB Abou-Alfa, GK	2020	32
	Single-nucleotide polymorphism (SNP) of excision repair cross complementation group 1 (ERCC1) in nasopharynx cancer (NPC): A companion biomarker study to Hong Kong NPC Study Group 0502 trial Proceeding/Conference:American Society of Clinical Oncology (ASCO) Annual Meeting 2014	Hui, EP Ma, B Chan, AKC Chan, CML Wong, CSC To, KF Chan, AWH Tung, SY Ng, WT Cheng, ACK Lee, VHF Chan, SL Loong, HHF Kam, MKM Leung, SF Ho, R Mo, F Lo, DYM Ngan, RKC Chan, ATC	2014	94
	Structural Behaviour of Bamboos for Access Scaffolding in Hong Kong Proceeding/Conference:Proceedings of the Sixth Asia Pacific Conference on Structural Engineering and Construction	Poon, SW Chan, SL	1998	103
	Study of dynamic debris impact load on flexible debris-resisting barriers and the dynamic pressure coefficient Journal:Canadian Geotechnical Journal	Lam, HWK Sze, EHY Wong, EKL Poudyal, S Ng, CWW Chan, SL Choi, CE	1-Dec-2022
	Sustained antitumor activity by co-targeting mTOR and the microtubule with temsirolimus/vinblastine combination in hepatocellular carcinoma Journal:Biochemical Pharmacology	Zhou, Q Lui, VWY Lau, CPY Cheng, SH Ng, MHL Cai, Y Chan, SL Yeo, W	2012	47
	Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma Journal:Gut	Liu, M Zhou, J Liu, X Feng, Y Yang, W Wu, F Cheung, OKW Sun, H Zeng, X Tang, W Mok, MTS Wong, J Yeung, PC Chen, Z Lai, PBS Jin, H Chen, J Chan, SL Chan, AWH To, KF Sung, JJ Chen, M Cheng, ASL	2019	55
	The ATP-binding cassette transporter ABCF1 is a hepatic oncofetal protein that promotes chemoresistance, EMT and cancer stemness in hepatocellular carcinoma Journal:Cancer Letters	Fung, SW Cheung, PFY Yip, CW Ng, LWC Cheung, TT Chong, CCN Lee, C Lai, PBS Chan, AWH Tsao, GSW Wong, CH Chan, SL Lo, KW Cheung, ST	2019	7
	The Hong Kong consensus statements on unresectable hepatocellular carcinoma: narrative review and update for 2021 Journal:Hepatobiliary Surgery and Nutrition	Cheung, TT Yu, SCH Chan, SL Poon, RTP Kwok, P Lee, AS Tai, A Tam, D Cheung, CC Lai, TW Chia, NH Law, A Shum, T Lam, YK Lau, V Lee, V Chong, C Tang, CN Yau, T	1-Jun-2023
	The preclinical activity of the histone deacetylase inhibitor PXD101 (belinostat) in hepatocellular carcinoma cell lines Journal:Investigational New Drugs	Ma, BBY Sung, F Tao, Q Poon, FF Lui, VW Yeo, W Chan, SL Chan, ATC	2010	47
	Tuberculosis in Hong Kong - patient characteristics and treatment outcome	Tam, CM Leung, CC Noertjojo, K Chan, SL Chan-Yeung, MMW	2003	197
	The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas Journal:Laboratory Investigation	Chan, SL Cui, Y Van Hasselt, A Li, H Srivastava, G Jin, H Ng, KM Wang, Y Lee, KY Tsao, GSW Zhong, S Robertson, KD Rha, SY Chan, ATC Tao, Q	2007
	Validation of the Hong Kong Chinese version of the St. George Respiratory Questionnaire in patients with bronchiectasis Journal:Chest	Chan, SL ChanYeung, MM Ooi, GC Lam, CL Cheung, TF Lam, WK Tsang, KW	2002	102

Showing results 25 to 41 of 41 < previous